Sunway Healthcare Holdings Bhd
Sunway Healthcare Holdings Bhd operates in the healthcare facilities and services industry, generating revenue primarily through pharmaceuticals and healthcare services.
Business. Sunway Healthcare Holdings Bhd (SUNA.KL) is a healthcare company engaged in healthcare facilities and services, with activities including pharmaceuticals. The firm operates on a service-revenue model within the Healthcare Services & Equipment sector. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on Bursa Malaysia.
Analyst recommendations
7 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
2Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Sunway Healthcare Holdings Bhd (SUNA.KL) is a healthcare company engaged in healthcare facilities and services, with activities including pharmaceuticals. The firm operates on a service-revenue model within the Healthcare Services & Equipment sector. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on Bursa Malaysia.
Sunway Healthcare Holdings Bhd has a debt-to-equity ratio of 0.64, indicating a moderate level of leverage, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -126,558,000 MYR, which is a concern for its ability to fund operations without external financing. The capital expenditure of -579,051,000 MYR indicates significant investment in long-term assets.
The company's profitability is reflected in a return on equity of 10.01% and a return on assets of 5.21%, which are metrics that are typically used in the healthcare industry to assess performance. The operating income of 310,136,000 MYR and net income of 252,212,000 MYR suggest a healthy margin, but the gross profit of 1,383,219,000 MYR indicates that the company is managing its cost of goods sold effectively.
Sunway Healthcare Holdings Bhd's revenue is concentrated in the pharmaceuticals segment, and there is no detailed breakdown of geographic exposure provided in the available data. The company's revenue of 2,200,389,000 MYR is a key indicator of its market position within the healthcare facilities and services industry.
The company's growth trajectory is not explicitly detailed in the available data, but the negative free cash flow and significant capital expenditure suggest that the company is investing in its future growth. The operating cash flow of 465,659,000 MYR indicates that the company is generating positive cash from its operations, which is a positive sign for its financial health.
The risk assessment indicates a medium liquidity risk and a low dilution risk, with a key flag noting that net cash is negative after subtracting total debt. The company's dilution potential is low, and there are no adjustments applied to the valuations that would suggest a significant risk of dilution.
Recent events and filings are not detailed in the available data, but the company's financial snapshot and valuation metrics provide a current view of its financial position.
- Sunway Healthcare Holdings Bhd has a moderate level of leverage with a debt-to-equity ratio of 0.64.
- The company's return on equity of 10.01% indicates strong profitability relative to its equity base.
- The negative free cash flow of -126,558,000 MYR suggests the company may need to seek external financing to fund operations.
- The company's operating cash flow of 465,659,000 MYR is a positive indicator of its ability to generate cash from operations.
- The capital expenditure of -579,051,000 MYR indicates significant investment in long-term assets.
- margin_outlook_rationale: The company's gross profit margin is strong, indicating effective cost management.
- rd_outlook_rationale: No specific information is available to assess the company's research and development outlook.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Sunway Healthcare Holdings Bhd Market data — financials · 2026-05-29
- Sunway Healthcare Holdings Bhd Market data — analyst estimates · 2026-05-29